Why Emergency COVID Vaccine Approvals Could Pose a Dilemma
Article

Why Emergency COVID Vaccine Approvals Could Pose a Dilemma

If approval comes before clinical trials end, this could complicate the study of vaccines’ long-term effects

David Cyranoski and Smriti Mallapaty
Nature, 2020

Related Summaries

Stem Cells 2 Go
Article

David Cyranoski and Brendan Maher

Stem Cells 2 Go

Japan has turned regenerative medicine into a regulatory free-for-all. Patients across the world could pay the price.
Gene-Edited Monkey Clones Stir Excitement and Debate
Article

David Cyranoski

Gene-Edited Monkey Clones Stir Excitement and Debate

Genetically identical primates offer the best models of human disease, but raise ethical issues.
What’s Next for CRISPR Babies?
Article

David Cyranoski

What’s Next for CRISPR Babies?

Following last year’s bombshell revelation, investigations mount and debates swirl about the future for gene-edited humans. Here are the four most pressing questions.
How China Could Be Carbon Neutral by Mid-Century
Article

Smriti Mallapaty

How China Could Be Carbon Neutral by Mid-Century

Our special report examines the role of renewables, nuclear power and carbon capture in reaching this ambitious goal.
Novavax’s Long-Awaited COVID-19 Vaccine Authorizations Offer an Alternative to mRNA
Article

Meredith Wadman

Novavax’s Long-Awaited COVID-19 Vaccine Authorizations Offer an Alternative to mRNA

European Commission and World Health Organization approvals usher in key addition to vaccine supply
Moonshot
Book

Dr. Albert Bourla

Moonshot

Inside Pfizer's Nine-Month Race to Make the Impossible Possible